Globe Newswire07.12.18
Merit Medical Systems Inc. has announced that Bernard Birkett has resigned as chief financial officer (CFO) to pursue other business opportunities. Birkett’s departure is not attributable to any disagreement with Merit’s accounting principles or practices or financial statement disclosures.
"We appreciate the contributions Bernard has made over the years in Europe and over the past few years on a company-wide basis and wish him all the best in his future endeavors,” said Fred P. Lampropoulos, Merit’s board chairman and CEO.
Raul Parra, C.P.A., a Merit veteran of more than eight years, has been appointed as the company’s interim CFO. Parra worked in various audit positions for Deloitte & Touche prior to joining Merit. During his tenure at Merit he has served in various roles, most recently as corporate controller and vice president of Accounting.
“Raul has built a very effective team over the past several years and has a great working relationship with the entire management team,” Lampropoulos said. “We are fortunate to have an experienced leader during this transition. Our efforts will continue to focus on our broad global infrastructure while meeting our objectives for the business.”
Founded in 1987, Merit Medical Systems Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Va.; Malvern, Pa.; Rockland, Mass.; San Jose, Calif.; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.
"We appreciate the contributions Bernard has made over the years in Europe and over the past few years on a company-wide basis and wish him all the best in his future endeavors,” said Fred P. Lampropoulos, Merit’s board chairman and CEO.
Raul Parra, C.P.A., a Merit veteran of more than eight years, has been appointed as the company’s interim CFO. Parra worked in various audit positions for Deloitte & Touche prior to joining Merit. During his tenure at Merit he has served in various roles, most recently as corporate controller and vice president of Accounting.
“Raul has built a very effective team over the past several years and has a great working relationship with the entire management team,” Lampropoulos said. “We are fortunate to have an experienced leader during this transition. Our efforts will continue to focus on our broad global infrastructure while meeting our objectives for the business.”
Founded in 1987, Merit Medical Systems Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Va.; Malvern, Pa.; Rockland, Mass.; San Jose, Calif.; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.